Dr. Christine Moore is a founding member of Organon where she leads Global External Advocacy and Standards, providing oversight for implementation of new GMP-related policy, compendial standards and analytical requirements. Christine started her career as an API process development engineer at Pfizer and Searle/Pharmacia, then moved to US FDA where she led the offices responsible for small molecule new drug review and manufacturing process assessment. In 2016, she returned to industry to advance regulatory policy and innovation at Merck and now Organon. Christine is a global thought leader in scientific and regulatory approaches for advancing pharmaceutical manufacturing technologies including continuous manufacturing, process analytical technologies, and portable/point of care manufacturing. She holds a PhD in chemical engineering from Massachusetts Institute of Technology and a BS in Chemical Engineering from Northwestern University.